Research solutions
Sample to Insight COVID-19 wastewater testing

A year into the COVID-19 pandemic, as we keep testing and tracing, there has been growing evidence that successful detection of SARS-CoV-2 RNA in wastewater or natural sewage is a powerful surveillance tool to prevent community outbreaks. QIAGEN supports wastewater-based epidemiology efforts with research tools spanning nucleic acid extraction, amplification and detection, overcoming some of the limitations and challenges in the analytical protocols along the workflow.

group of scientist, talk, discussion, laboratory, diversity, wearing masks
Best in class sample prep

Given the current public health emergency with COVID-19, QIAGEN and other companies are facing unprecedented demand for viral RNA isolation solutions. QIAGEN has developed dedicated solutions for viral RNA isolation that have been optimized for maximum sensitivity and reproducibility.

We recognize that currently, scientists are seeking to use various QIAGEN kits, such as RNeasy, for SARS-CoV-2 RNA isolation from respiratory samples. It is critical to note that these kits have not been designed for isolating viral RNA, and performance of each kit varies. The user must consult the product-specific handbook or user manual. We strongly recommend using only dedicated RNA isolation products for SARS-CoV-2, such as those listed below:

For QIAcube classic information please visit our resource hub.
Innovative PCR solution for epidemiological research

The QIAprep&amp Viral RNA UM Kit is an innovative, liquid-based approach to viral RNA epidemiology. In one streamlined kit, it combines a two-minute sample preparation with RT-qPCR detection that takes under one hour to generate data. With a simple, three-step workflow, with the possibilities for automation, this kit can significantly accelerate the turnaround time and frequency for epidemiological research.

NGS resources for coronavirus research

The new QIAseq SARS-CoV-2 Primer Panel enables targeted enrichment and deep sequencing of the complete SARS-CoV-2 genome. With a single-day workflow, and the ability to multiplex up to 384 samples when combined with the QIAseq FX DNA Library UDI Kit, this NGS panel provides faster results – with lower input requirements – compared with hybrid capture approaches. Rapid sequence and phylogenetic data analysis are also available using pre-built and optimized pipelines in the QIAGEN CLC Genomics Workbench. Obtain a trial kit of the QIAseq SARS-CoV-2 Primer Panel and learn more about the complete solution here.

Whole genomic sequencing services

QIAGEN Genomic Services provides a comprehensive Sample-to-Insight SARS-CoV-2 Whole Genome Sequencing Services to support your research. Whether you’re studying strain evolution or performing phylogeographic or metagenomic analyses, Genomic Services is the right partner for providing impactful insights and helping accelerate your COVID-19 research. This service uses technology especially designed for SARS-CoV-2 research.

QIAGEN Genomic Service Capabilities
Bioinformatics analysis of SARS-CoV-2 with QIAGEN Digital Insights

To support the efforts of clinical microbiology and public health laboratories involved in SARS-CoV-2 sequencing, QIAGEN offers free temporary licenses to QIAGEN CLC Genomics and QIAGEN Ingenuity Pathway Analysis (IPA) bioinformatics software. In addition, until June 30, 2021 we are offering labs that purchase the QIAseq SARS-CoV-2 Primer Panel Kit (96) a 25% discount off any 1-year subscription to QIAGEN CLC Genomics bioinformatics software.

Additionally, our data scientists have expanded upon recent peer-reviewed research to generate relevant SARS-CoV-2 protein networks. This freely available Coronavirus Network Explorer helps you visualize how SARS-CoV-2 proteins interact with human host proteins to disable protective responses and pathways, and explore hypotheses around ways to fight coronavirus. 

Maximize insights from SARS-CoV-2 T cell immune response

T cells are increasingly recognized for their role in SARS-CoV-2 infection and immunity, and the exploration of immune response markers during COVID-19 infection is becoming the next tool for researching potential improvements in patient management and vaccination guidance in the future.

The QuantiFERON SARS-CoV-2 RUO solution uses a combination of antigens specific to SARS-CoV-2 to stimulate lymphocytes in heparinized whole blood. Plasma from the stimulated samples can be used for detection of cytokines, including IFN-γ.

QFT, QuantiFERON, tubes
Tailored oligonucleotides for SARS-CoV-2 detection

In our effort to support the detection of the SARS-CoV-2 virus, OEM by QIAGEN has ramped up the production of SARS-CoV-2 specific primers and probes. We provide customized oligos defined by our customers, as well as those mentioned in protocols recommended by WHO and the CDC. To meet the high demands, we are currently prioritizing the orders of SARS-CoV-2 specific oligonucleotides. In addition, we have introduced pre-manufacturing of these oligonucleotides to enable quick supply and delivery. To order please send your requests here.

QIAGEN solutions


How can we support your lab?

Reach a specialist about SARS-CoV-2 resources

Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.